Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency

Abstract

Genes from the RAF family are Ras-regulated kinases involved in growth cellular responses. Recently, a V599E hotspot mutation within the BRAF gene was reported in a high percentage of colorectal tumors and significantly associated to defective mismatch repair (MMR). Additionally, BRAF mutations were described only in K-Ras-negative colon carcinomas, suggesting that BRAF/K-Ras activating mutations might be alternative genetic events in colon cancer. We have addressed to what extent the tumorigenic-positive selection exerted by BRAF mutations seen in colorectal MMR-deficient tumors was also involved in the tumorigenesis of gastric cancer. Accordingly, BRAF mutations were detected in 34% (25/74) of colorectal MMR-deficient tumors and in 5% (7/142) of MMR-proficient colorectal cases (P=0.0001). All mutations found in the MSI cases corresponded to the previously reported hotspot V599E. Two D593K and a K600E additional mutations were also detected in three MSS cases. However, only one mutation of BRAF was found within 124 MSS gastric tumors and none in 37 MSI gastric tumors, clearly suggesting that BRAF mutations are not involved in gastric tumorigenesis. Nonetheless, a high incidence of mutations of K-Ras was found within the MSI gastric group of tumors (P=0.0005), suggesting that the activation of K-Ras-dependent pathways contributes to the tumorigenesis of gastric cancers with MMR deficiency. Accordingly, our results show evidences that BRAF mutations characterize colon but not gastric tumors with MMR deficiency and are not involved in the tumorigenesis of gastric cancer of the mutator phenotype pathway.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B and de la Chapelle A . (1993). Science, 260, 812–816.

  • Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodrigues-Bigas MA, Fodde R, Ranzani GN and Srivastava S . (1998). Cancer Res., 58, 5248–5257.

  • Brennetot C, Pinto M, Oliveira C, Schwartz Jr S, Seruca R, Duval A and Hamelin R : Gastroenterology. (in press).

  • Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JWC, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR and Futreal PA . (2002). Nature, 417, 949–954.

  • Duval A and Hamelin R . (2002). Cancer Res., 62, 2447–2454.

  • Gayet J, Zhou XP, Duval A, Rolland S, Hoang JM, Cottu P and Hamelin R . (2001). Oncogene, 20, 5025–5032.

  • Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G and Hamelin R . (1997). Cancer Res., 57, 300–303.

  • Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M . (1993). Nature, 363, 558–561.

  • Oliveira C, Seruca R, Seixas M and Sobrinho-Simões M . (1998). Am. J. Pathol., 153, 1211–1219.

  • Perucho M . (1996). J. Biol. Chem., 377, 675–684.

  • Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B and Velculescu VE . (2002). Nature, 418, 934.

  • Schwartz Jr S, Yamamoto H, Navarro M, Maestro M, Reventós J and Perucho M . (1999). Cancer Res., 59, 2995–3002.

  • Thibodeau SN, Bren G and Schaid D . (1993). Science, 260, 816–819.

  • Yamamoto H, Fukushima H, Itoh F, Horiuchi S, Min Y, Iku S and Imai K . (2001). J. Exp. Clin. Cancer Res., 20, 553–559.

  • Yamamoto H, Perez-Piteira J, Yoshida T, Terada M, Itoh F, Imai K and Perucho M . (1999). Gastroenterology, 116, 1348–1357.

  • Yamamoto H, Sawai H and Perucho M . (1997). Cancer Res., 57, 4420–4426.

  • Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, Stephens P, Edkins S, Tsui WW, Chan AS, Futreal PA, Stratton MR, Wooster R and Leung SY . (2002). Cancer Res., 62, 6451–6455.

Download references

Acknowledgements

This work was supported by Grant FIS 01/1350 from the Spanish Fondo de Investigaciones Sanitarias and Fundação para a Ciência e a Tecnologia, Portugal (Project: POCTI/35374/CBO/2000 and POCTI/CBO/40820/2001).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simó Schwartz Jr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oliveira, C., Pinto, M., Duval, A. et al. BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency. Oncogene 22, 9192–9196 (2003). https://doi.org/10.1038/sj.onc.1207061

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207061

Keywords

This article is cited by

Search

Quick links